Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • IDX revenue remains steady despite ongoing spicy flu woes
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • IDX revenue remains steady despite ongoing spicy flu woes
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • IDX revenue remains steady despite ongoing spicy flu woes
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • IDX revenue remains steady despite ongoing spicy flu woes
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • IDX revenue remains steady despite ongoing spicy flu woes
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • Mach7 completes largest renewal program in its history with DocPanel
    Mach7 completes largest renewal program in its history with DocPanel
    • News

  • Labour shortages and cost inflation slug Integral Diagnostics, hopes for better second half than first
    Labour shortages and cost inflation slug Integral Diagnostics, hopes for better second half than first
    • News

  • Cyclopharm gets FDA green light to sell its lung imaging tech Technegas in the US
    Cyclopharm gets FDA green light to sell its lung imaging tech Technegas in the US
    • News

  • IMEXHS seals the deal with Colombia’s fifth largest health insurer
    IMEXHS seals the deal with Colombia’s fifth largest health insurer
    • News

  • IDX revenue remains steady despite ongoing spicy flu woes
    IDX revenue remains steady despite ongoing spicy flu woes
    • News

  • Bumper result for Baby Bunting as bubs get plenty of pandemic lovin’
    • News

    Bumper result for Baby Bunting as bubs get plenty of pandemic lovin’

    Through COVID-19, one of the better problems for retail businesses has been to not qualify for JobKeeper support, and is the case for Baby Bunting (ASX: BBN) which reported bumper FY20 sales of $405m, an 11.8% increase on the previous year. Strong results for the baby products retailer come despite disruption caused through the pandemic,

    Read More
    Public
  • Fiji Kava engaged by top healthcare company for anxiety treatment
    • News

    Fiji Kava engaged by top healthcare company for anxiety treatment

    Anxiety sufferers may soon have a new alternative natural treatment available to them with health and wellness company Fiji Kava (ASX: FIJ) to supply noble kava extract to BioCeuticals, a healthcare products company owned by Blackmores (ASX: BKL). The supply agreement will provide BioCeuticals with noble kava extract to be used in their AnxioCalm products

    Read More
    Public
  • BlackEarth secures Tier 1 global offtake partner for their high-quality graphite
    • News

    BlackEarth secures Tier 1 global offtake partner for their high-quality graphite

    Following significant testing on their graphite to confirm its high-quality specifications, BlackEarth Minerals (ASX: BEM) has secured a Tier 1 offtake partner with top European refractory company RHI Magnesita (LSE: RHIM) entering a binding agreement to purchase BlackEarth’s graphite.  The Memorandum of Understanding will see BlackEarth work closely with RHIM to produce “tailor-made” graphite concentrate

    Read More
    Public
  • A beer fortune turnaround Broo-ing with large CUB order
    • News

    A beer fortune turnaround Broo-ing with large CUB order

    Despite some struggles faced through COVID-19 shutdowns, beer producer Broo (ASX: BEE) could be on the move again having entered into a production agreement with Australia’s leading brewer Carlton and United Breweries (CUB).  The order with CUB comes despite Broo owning and operating their own brewery facility in Mildura where they produce Broo Premium Lager

    Read More
    Public
  • Earnings Results: James Hardie and Shopping Centres Australasia
    • News

    Earnings Results: James Hardie and Shopping Centres Australasia

     James Hardie Industries (ASX: JHX) – Q1FY21 Results Announcement James Hardie today announced their Q1 FY21 results. Net operating profit (NOPAT) ran at around $US89.3 million for the quarter, which was in-line with the prior corresponding period. The company has announced full-year FY21 guidance for NOPAT of between $US330 million and $US390 million (FY20: $US352.8

    Read More
    Public
  • Gage Roads to launch flagship entertainment venue in WA tourism hub
    • News

    Gage Roads to launch flagship entertainment venue in WA tourism hub

    Fremantle Harbour’s Victoria Quay will soon become the spiritual home of Gage Roads Brewing (ASX: GRB) which has secured the iconic A Shed for a multi-discipline entertainment venue within the emerging tourism precinct. The A Shed, which played a key role in the establishment of Fremantle as a harbour town, will be re-designed by Gage

    Read More
    Public
  • IVE shares tumble as Coles ends printed catalogue delivery to 7 million households
    • News

    IVE shares tumble as Coles ends printed catalogue delivery to 7 million households

    Kids looking for delivery routes as their first job have perhaps had the opportunity taken away from them thanks to technology, with Coles (ASX: COL) ending delivery of their weekly catalogues to more than 7 million Australian households.  Printed copies of catalogues will still be available in-store but the 14,000 walkers managed by marketing company

    Read More
    Public
  • Atomo’s rapid COVID-19 test approved by TGA for distribution
    • News

    Atomo’s rapid COVID-19 test approved by TGA for distribution

    Australians will soon have access to a rapid COVID-19 test where results can be obtained in just 15 minutes from a drop of blood following approval from the Therapeutic Goods Association (TGA) for Atomo Diagnostics’ (ASX: AT1) rapid antibody test. The test device has been independently tested at laboratories in France where the AtomoRapid test

    Read More
    Public
  • Healthia secures Queensland Rugby naming rights till end of 2021
    • News

    Healthia secures Queensland Rugby naming rights till end of 2021

    Allied healthcare provider Healthia (ASX: HLA) has strengthened its position as the leading physiotherapy and podiatry provider in Queensland having secured the naming rights for State’s top club rugby competition until the end of 2021. The Allsports Physiotherapy Hospital Challenge Cup resumed at the start of August following a COVID-19 hiatus and continues Healthia’s long

    Read More
    Public
  • Adairs rides online retail boom with record homemaker sales and profit
    • News

    Adairs rides online retail boom with record homemaker sales and profit

    Australians and Kiwis are likely to be very comfortable at home through pandemic isolation if the record sales of homemaker retailer Adairs (ASX: ADH) are an indicator, with the Company’s online sales up 110.5% for FY20. Although the pandemic caused closures of their retail stores across Australia and New Zealand for a few months, Adairs

    Read More
    Public
  • «
  • ‹
  • 280
  • 281
  • 282
  • 283
  • 284
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.